
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20241206
[patent_doc_number] => 12421515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Method of stimulating proliferation of a cell
[patent_app_type] => utility
[patent_app_number] => 17/731259
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 194
[patent_no_of_words] => 72629
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731259 | Method of stimulating proliferation of a cell | Apr 26, 2022 | Issued |
Array
(
[id] => 20241206
[patent_doc_number] => 12421515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Method of stimulating proliferation of a cell
[patent_app_type] => utility
[patent_app_number] => 17/731259
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 194
[patent_no_of_words] => 72629
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731259 | Method of stimulating proliferation of a cell | Apr 26, 2022 | Issued |
Array
(
[id] => 18647866
[patent_doc_number] => 20230293642
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-09-21
[patent_title] => TREATMENT AND DETECTION OF INHERITED NEUROPATHIES AND ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/719580
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719580 | Treatment and detection of inherited neuropathies and associated disorders | Apr 12, 2022 | Issued |
Array
(
[id] => 18647866
[patent_doc_number] => 20230293642
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-09-21
[patent_title] => TREATMENT AND DETECTION OF INHERITED NEUROPATHIES AND ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/719580
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719580 | Treatment and detection of inherited neuropathies and associated disorders | Apr 12, 2022 | Issued |
Array
(
[id] => 17776471
[patent_doc_number] => 20220242820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/658075
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/658075 | Ionizable compounds and compositions and uses thereof | Apr 4, 2022 | Issued |
Array
(
[id] => 17911331
[patent_doc_number] => 20220313726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/711137
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711137 | Methods of treating metabolic disorders and cardiovascular disease with Inhibin Subunit Beta E (INHBE) inhibitors | Mar 31, 2022 | Issued |
Array
(
[id] => 18666515
[patent_doc_number] => 11773393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/709705
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 10
[patent_no_of_words] => 65829
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709705 | Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors | Mar 30, 2022 | Issued |
Array
(
[id] => 17960322
[patent_doc_number] => 20220340902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => METHODS FOR TREATING SARS-COV-2 INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/709282
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709282 | Methods for treating SARS-CoV-2 infection | Mar 29, 2022 | Issued |
Array
(
[id] => 17748160
[patent_doc_number] => 20220226363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SARS-COV-2 INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/709275
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709275 | Compositions and methods for treating SARS-CoV-2 infection | Mar 29, 2022 | Issued |
Array
(
[id] => 18211912
[patent_doc_number] => 20230058176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SWITCHABLE CAS9 NUCLEASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/688416
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17688416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/688416 | Switchable Cas9 nucleases and uses thereof | Mar 6, 2022 | Issued |
Array
(
[id] => 18211912
[patent_doc_number] => 20230058176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SWITCHABLE CAS9 NUCLEASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/688416
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17688416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/688416 | Switchable Cas9 nucleases and uses thereof | Mar 6, 2022 | Issued |
Array
(
[id] => 17897363
[patent_doc_number] => 20220307025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => PROCESS OF DELIVERING SMALL RNAS TO SPERM
[patent_app_type] => utility
[patent_app_number] => 17/686352
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686352 | PROCESS OF DELIVERING SMALL RNAS TO SPERM | Mar 2, 2022 | Pending |
Array
(
[id] => 17958609
[patent_doc_number] => 20220339189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => METHOD OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/653221
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653221 | METHOD OF TREATING CANCER | Mar 1, 2022 | Pending |
Array
(
[id] => 17958609
[patent_doc_number] => 20220339189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => METHOD OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/653221
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653221 | METHOD OF TREATING CANCER | Mar 1, 2022 | Pending |
Array
(
[id] => 18193933
[patent_doc_number] => 20230047452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => MODULATORS OF DIACYGLYCEROL ACYLTRANSFERASE 2 (DGAT2)
[patent_app_type] => utility
[patent_app_number] => 17/677875
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677875 | Modulators of diacyglycerol acyltransferase 2 (DGAT2) | Feb 21, 2022 | Issued |
Array
(
[id] => 17673055
[patent_doc_number] => 20220186222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/671924
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/671924 | Linkage modified oligomeric compounds and uses thereof | Feb 14, 2022 | Issued |
Array
(
[id] => 18077729
[patent_doc_number] => 20220403341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => EXOSOMES FROM CLONAL PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/592200
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592200 | EXOSOMES FROM CLONAL PROGENITOR CELLS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17625865
[patent_doc_number] => 20220160880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ANTISENSE NUCLEIC ACID TARGETING PCSK9
[patent_app_type] => utility
[patent_app_number] => 17/649895
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17649895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/649895 | ANTISENSE NUCLEIC ACID TARGETING PCSK9 | Feb 2, 2022 | Pending |
Array
(
[id] => 17625865
[patent_doc_number] => 20220160880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ANTISENSE NUCLEIC ACID TARGETING PCSK9
[patent_app_type] => utility
[patent_app_number] => 17/649895
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17649895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/649895 | ANTISENSE NUCLEIC ACID TARGETING PCSK9 | Feb 2, 2022 | Pending |
Array
(
[id] => 20401300
[patent_doc_number] => 12491260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Compositions and methods for delivery of agents
[patent_app_type] => utility
[patent_app_number] => 17/583674
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 123
[patent_figures_cnt] => 159
[patent_no_of_words] => 99343
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583674 | Compositions and methods for delivery of agents | Jan 24, 2022 | Issued |